{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:03:25Z","timestamp":1790129005930,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e01060","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:15:10Z","timestamp":1789071310000},"page":"e01060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiometabolic disease is associated with distinct proteomic signatures of acute disease activity in multiple sclerosis"],"prefix":"10.1016","volume":"23","author":[{"given":"Darin T.","family":"Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy W.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan C.","family":"Jones-McCreary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella J.","family":"Huddleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Santoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Punnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Sguigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Tardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lebrun-Fr\u00e9nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"St\u00fcve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diem H.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatum M.","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neurot.2026.e01060_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/13524585241245306","article-title":"Radiologically isolated syndrome in the spectrum of multiple sclerosis","volume":"30","author":"Okuda","year":"2024","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01060_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01060_bib3","first-page":"e212","volume":"82","author":"Writing Committee","year":"2025","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2026.e01060_bib4","first-page":"S20","article-title":"Diagnosis and classification of diabetes: standards of care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurot.2026.e01060_bib5","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.neurot.2026.e01060_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109688","article-title":"Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis","volume":"253","author":"Chitnis","year":"2023","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01060_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01060_bib8","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1212\/WNL.0000000000010024","article-title":"Comorbidity is associated with disease activity in MS: findings from the CombiRx trial","volume":"95","author":"Salter","year":"2020","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01060_bib9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamaneurol.2024.2920","article-title":"Comorbidity and disease activity in multiple sclerosis","volume":"81","author":"Salter","year":"2024","journal-title":"JAMA Neurol"},{"issue":"22","key":"10.1016\/j.neurot.2026.e01060_bib10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1212\/WNL.0000000000004686","article-title":"Assessing association of comorbidities with treatment choice and persistence in MS: a real-life multicenter study","volume":"89","author":"Laroni","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01060_bib11","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1212\/WNL.0000000000004885","article-title":"Effects of physical comorbidities on disability progression in multiple sclerosis","volume":"90","author":"Zhang","year":"2018","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.neurot.2026.e01060_bib12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1042\/CS20257214","article-title":"Chemokine receptors in vascular biology: a review of current evidence, implications, and therapeutic targets for hypertension","volume":"139","author":"Oliveira de Moraes","year":"2025","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01060_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","article-title":"Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition","volume":"6","author":"Hameed","year":"2015","journal-title":"World J Diabetes"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01060_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01060_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mayocpiqo.2021.11.004","article-title":"Physical and mental health comorbidities among adults with multiple sclerosis","volume":"6","author":"Peterson","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.neurot.2026.e01060_bib16","series-title":"R: a language and environment for statistical computing","year":"2025"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01060_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202200018","article-title":"Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis","volume":"17","author":"Qureshi","year":"2023","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01060_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01060_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01060_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11481-017-9752-7","article-title":"Blood brain barrier injury in diabetes: unrecognized effects on brain and cognition","volume":"12","author":"Bogush","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01060_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2025.104820","article-title":"Hyperglycemia-induced blood-brain barrier dysfunction: mechanisms and therapeutic interventions","volume":"160","author":"Chen","year":"2025","journal-title":"Microvasc Res"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01060_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41371-020-0352-2","article-title":"Blood-brain barrier dysfunction: the undervalued frontier of hypertension","volume":"34","author":"Katsi","year":"2020","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01060_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01060_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood-brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Exp Physiol"},{"key":"10.1016\/j.neurot.2026.e01060_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/184042","article-title":"Dyslipidemia and blood-brain barrier integrity in alzheimer's disease","volume":"2012","author":"Bowman","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01060_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","article-title":"Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier","volume":"63","author":"Biancardi","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01060_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01060_bib28","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/HYPERTENSIONAHA.123.22617","article-title":"Blood-brain barrier integrity decreases with higher blood pressure: a 7T DCE-MRI study","volume":"81","author":"van den Kerkhof","year":"2024","journal-title":"Hypertension"},{"issue":"5381","key":"10.1016\/j.neurot.2026.e01060_bib29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signaling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01060_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.cdd.4400692","article-title":"Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells","volume":"7","author":"Wendling","year":"2000","journal-title":"Cell Death Differ"},{"issue":"Pt 11","key":"10.1016\/j.neurot.2026.e01060_bib31","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1093\/brain\/awf254","article-title":"TRAIL induces death of human oligodendrocytes isolated from adult brain","volume":"125","author":"Matysiak","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e01060_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ebiom.2017.11.023","article-title":"Elevated markers of death receptor-activated apoptosis are associated with increased risk for development of diabetes and cardiovascular disease","volume":"26","author":"Mattisson","year":"2017","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01060_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144015","article-title":"Soluble TRAIL concentration in serum is elevated in people with hypercholesterolemia","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01060_bib34","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/s41366-022-01194-0","article-title":"Heart failure in obesity: insights from proteomics in patients treated with or without weight-loss surgery","volume":"46","author":"Karason","year":"2022","journal-title":"Int J Obes"},{"issue":"36","key":"10.1016\/j.neurot.2026.e01060_bib35","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1523\/JNEUROSCI.1520-10.2010","article-title":"Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection","volume":"30","author":"Bartsch","year":"2010","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01060_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2012.11.012","article-title":"Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node","volume":"38","author":"Kastenmuller","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.neurot.2026.e01060_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2026.156586","article-title":"The dual role of CCL20 in inflammatory disease: maintenance of host defense and immunopathological balance","volume":"286","author":"Xu","year":"2026","journal-title":"Pathol Res Pract"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01060_bib38","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01060_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1037\/0022-3514.79.6.995","article-title":"When choice is demotivating: can one desire too much of a good thing?","volume":"79","author":"Iyengar","year":"2000","journal-title":"J Pers Soc Psychol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01060_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.apmr.2021.10.011","article-title":"Differences in cardiometabolic comorbidities between black and white persons living with multiple sclerosis","volume":"103","author":"Chase","year":"2022","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01060_bib41","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000102","article-title":"Early CNS neurodegeneration in radiologically isolated syndrome","volume":"2","author":"Azevedo","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurot.2026.e01060_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1352458519887346","article-title":"Cerebellar volume loss in radiologically isolated syndrome","volume":"27","author":"George","year":"2021","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01060_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","article-title":"The neuropathobiology of multiple sclerosis","volume":"25","author":"Woo","year":"2024","journal-title":"Nat Rev Neurosci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:08:25Z","timestamp":1790125705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926002308"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01060","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiometabolic disease is associated with distinct proteomic signatures of acute disease activity in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01060"}}